197 related articles for article (PubMed ID: 6525601)
41. Phase II study of doxorubicin and mitomycin in non-small cell bronchogenic carcinoma.
Coates AS; Fox RM; Woods RL; Levi JA; Tattersall MH
Cancer Treat Rep; 1982 Jan; 66(1):177-8. PubMed ID: 7053255
[TBL] [Abstract][Full Text] [Related]
42. Some thoughts on surgical adjuvant studies in lung cancer.
Carter SK
Cancer Chemother Rep 3; 1973 Mar; 4(2):109-17. PubMed ID: 4729314
[No Abstract] [Full Text] [Related]
43. Antitumor drugs in inoperable lung cancer.
Behera D; Malik SK
Indian J Chest Dis Allied Sci; 1984; 26(1):60-1. PubMed ID: 6510992
[No Abstract] [Full Text] [Related]
44. Phase II trial of mitoxantrone in advanced primary liver cancer: a Cancer and Leukemia Group B Study.
Davis RB; Van Echo DA; Leone LA; Henderson ES
Cancer Treat Rep; 1986 Sep; 70(9):1125-6. PubMed ID: 3742493
[No Abstract] [Full Text] [Related]
45. [Spirazidin in the complex treatment of lung cancer].
Shkrob OS; Zharikov AA
Khirurgiia (Mosk); 1970 Aug; 46(8):17-22. PubMed ID: 5473666
[No Abstract] [Full Text] [Related]
46. Radicality of surgery after inductive chemotherapy of bronchogenic cancer.
Novák K; Pesek M; Tauchman A; Bürger J; Chudácek Z
Acta Univ Palacki Olomuc Fac Med; 2000; 143():98-9. PubMed ID: 11144147
[No Abstract] [Full Text] [Related]
47. Phase II clinical evaluation of dihydroxyanthracenedione in patients with advanced lung cancer.
Valdivieso M; Umsawasdi T; Spitzer G; Chiuten DF; Booser DJ; Dhingra HM; Bodey GP
Am J Clin Oncol; 1984 Jun; 7(3):241-4. PubMed ID: 6328968
[TBL] [Abstract][Full Text] [Related]
48. Weekly mitoxantrone therapy for refractory multiple myeloma: a Southeastern Cancer Study Group Trial.
Esseesse I; Bartolucci AA; Gams RA; Silberman H; Velez-Garcia E; Cohen HJ; Omura GA
Cancer Treat Rep; 1986 May; 70(5):669-70. PubMed ID: 3708615
[No Abstract] [Full Text] [Related]
49. Papers presented at a symposium on cancer chemotherapy in the 1980's. Monte Carlo, 11th-12th October, 1984.
Invest New Drugs; 1985; 3(2):79-222. PubMed ID: 3894281
[No Abstract] [Full Text] [Related]
50. Treatment of metastatic sarcomas with mitoxantrone.
Presant CA; Gams R; Bartolucci AA
Cancer Treat Rep; 1984 May; 68(5):813-4. PubMed ID: 6722837
[No Abstract] [Full Text] [Related]
51. Panel report. Interdisciplinary group on clinical trials (biostatistics).
Zelen M
Cancer Chemother Rep 3; 1973 Mar; 4(2):317-9. PubMed ID: 4580859
[No Abstract] [Full Text] [Related]
52. [Results of synchronizing chemotherapy in bronchogenic carcinoma].
Grassi GG; Pozzi E
G Ital Chemioter; 1976; 23(1):55-62. PubMed ID: 801001
[No Abstract] [Full Text] [Related]
53. Phase II trial of mitomycin, vinblastine, and cisplatin (MVP) in non-small cell bronchogenic carcinoma.
Schulman P; Budman DR; Weiselberg L; Vinciguerra V; Degnan TJ
Cancer Treat Rep; 1983 Oct; 67(10):943-5. PubMed ID: 6684988
[TBL] [Abstract][Full Text] [Related]
54. Mitoxantrone in advanced bladder carcinoma. A phase II study of the EORTC Genito-urinary Tract Cancer Cooperative Group.
van Oosterom AT; Fosså SD; Mulder JH; Calciati A; de Pauw M; Sylvester R
Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1013-4. PubMed ID: 4065174
[TBL] [Abstract][Full Text] [Related]
55. A phase II study of dihydroxyanthracenedione (DHAD, mitoxantrone, NSC 301739) in advanced malignant melanoma.
Arseneau JC; Schoenfeld DA; Borden EC
Invest New Drugs; 1986; 4(1):53-6. PubMed ID: 3700041
[TBL] [Abstract][Full Text] [Related]
56. Phase I clinical trial with ametantrone (NSC-287513).
Piccart M; Rozencweig M; Abele R; Cumps E; Dodion P; Dupont D; Kisner D; Kenis Y
Eur J Cancer Clin Oncol; 1981 Jul; 17(7):775-9. PubMed ID: 7199472
[No Abstract] [Full Text] [Related]
57. Mitoxantrone.
Nathanson L
Cancer Treat Rev; 1984 Dec; 11(4):289-93. PubMed ID: 6534511
[No Abstract] [Full Text] [Related]
58. Preliminary observations on the Ledakrin effects in treatment of patients with lung carcinoma.
Kwasniewska-Rokicińska C; Swiecki J; Drosik K
Mater Med Pol; 1976; 8(3):289-94. PubMed ID: 1011871
[No Abstract] [Full Text] [Related]
59. Combination chemotherapy for bronchogenic carcinoma with doxorubicin, BCNU, and cyclophosphamide (ABC): a pilot study of the Southeastern Cancer Study Group.
Denes AE; Presant CA; Bartolucci A
Cancer Treat Rep; 1982 Jan; 66(1):199-200. PubMed ID: 7053258
[No Abstract] [Full Text] [Related]
60. New agents and combinations in the treatment of bronchogenic carcinoma.
Bodey GP; Gottlieb JA; Livingston R; Frei E
Cancer Chemother Rep 3; 1973 Mar; 4(2):227-9. PubMed ID: 4125740
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
